Thursday, 04 June 2020 5:48 amAvacta Group, the Aim-listed developer of a saliva test for Coronavirus, is said to be looking to tap investors for up to £30 million.
Wednesday, 20 May 2020 7:42 amHitting the RNS this morning is some fresh news about how a company backed by Mahmud Kamani has signed a deal to distribute some Covid-19 tests being developed by Aim-listed Avacta.
Saturday, 19 October 2019 7:17 amOh look - I see Avacta Group, the Aim-listed biotechnology company, has effectively confirmed little old Betaville's RARE alert from yesterday morning.
